Corneal Crosslinking for Treatment of Corneal Neovascularization

Description

The study objective is to assess safety and efficacy of photo-activation of riboflavin for treatment of corneal neovascularization with or without concomitant inflammation and/or infection.

Conditions

Corneal Neovascularization

Talk to us

Study Overview

On this page

Study Details

Study overview

The study objective is to assess safety and efficacy of photo-activation of riboflavin for treatment of corneal neovascularization with or without concomitant inflammation and/or infection.

Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Corneal Neovascularization With or Without Concomitant Inflammation and/or Infection

Corneal Crosslinking for Treatment of Corneal Neovascularization

Condition
Corneal Neovascularization
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Price Vision Group, Indianapolis, Indiana, United States, 46260

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age or older
  • * With active inflammation or infection causing vascularization and possibly melting of the cornea, or vessels extending into the cornea causing lipid deposition, or vascularization that could significantly increase the risk of rejection of a current or planned corneal transplant, or vessels that continue to extend into the cornea despite topical treatment with corticosteroids.
  • * Signed written informed consent.
  • * Known sensitivity to treatment medications
  • * Current condition that in the investigator's opinion could compromise safety or data integrity.
  • * Pregnancy (including plan to become pregnant) or lactation during the course of the study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Price Vision Group,

Francis W Price, Jr., MD, PRINCIPAL_INVESTIGATOR, Price Vision Group

Study Record Dates

2025-09-15